Aesthetic Injectables | Market Insights | US | 2021
Although it will be negatively affected by the COVID-19 pandemic in the short term, the US market for aesthetic injectables will grow through 2029, driven primarily by high patient demand, including from emerging patient groups such as men and younger individuals. New advancements in treatments and products—including product approvals for expanded indications for existing products—will also contribute to market growth.
This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for aesthetic injectable in the US across a 10-year period.
